Sign In
Buy ACET
$9.11
+0.0500 (+0.552%)
At Close: Jul 31, 2026
What Makes Adicet Bio, Inc. (ACET) a Good Fit for 'Trend Investing'
10:32am, Wednesday, 07'th Dec 2022
Adicet Bio, Inc. (ACET) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
REDWOOD CITY, Calif. & BOSTON--( BUSINESS WIRE )--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer,
Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit
04:00pm, Wednesday, 30'th Nov 2022
REDWOOD CITY, Calif. & BOSTON--( BUSINESS WIRE )--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer,
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
11:17am, Friday, 11'th Nov 2022
Here is how Adicet Bio, Inc. (ACET) and RxSight, Inc. (RXST) have performed compared to their sector so far this year.
Adicet Bio, Inc. (ACET) Reports Q3 Loss, Misses Revenue Estimates
07:33pm, Tuesday, 08'th Nov 2022
Adicet Bio, Inc. (ACET) delivered earnings and revenue surprises of 5.36% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Adicet Bio to Present at Upcoming Investor Conferences
04:10pm, Wednesday, 07'th Sep 2022
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antige
Adicet Bio, Inc. (ACET) Reports Q2 Loss, Misses Revenue Estimates
09:47am, Wednesday, 10'th Aug 2022
Adicet Bio, Inc. (ACET) delivered earnings and revenue surprises of -24.44% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
7 Cheap Biotech Stocks to Buy Now
04:42pm, Wednesday, 03'rd Aug 2022
Biopharmaceutical companies have been struggling since 2021 and that narrative isn't immediately changing. However, not every firm deserves this fate.
Adicet Bio to Present at Upcoming Investor Conferences
04:10pm, Monday, 01'st Aug 2022
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antige
Adicet Bio: A First Take
12:05pm, Friday, 22'nd Jul 2022
Today, we take a look at Adicet Bio for the first time. The company is pioneering what it hopes will be among the next wave of CAR-T therapies and is advancing its lead candidate.
Adicet Bio, Inc. (ACET) Is a Great Choice for "Trend" Investors, Here's Why
10:04am, Monday, 18'th Jul 2022
Adicet Bio, Inc. (ACET) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Has Adicet Bio (ACET) Outpaced Other Medical Stocks This Year?
10:53am, Thursday, 14'th Jul 2022
Here is how Adicet Bio, Inc. (ACET) and Catalyst Biosciences, Inc. (CBIO) have performed compared to their sector so far this year.
Adicet Bio to Present at Upcoming Investor Conferences
04:10pm, Tuesday, 21'st Jun 2022
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antige
Adicet Bio to Present at Upcoming Investor Conferences
04:00pm, Wednesday, 18'th May 2022
MENLO PARK, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen
Adicet Bio, Inc. (ACET) Surges 6.8%: Is This an Indication of Further Gains?
09:49am, Thursday, 28'th Apr 2022
Adicet Bio, Inc. (ACET) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc
